🇺🇸 FDA
Patent

US 11040965

Process for making Hepatitis B core protein modulators

granted A61PA61P31/20

Quick answer

US patent 11040965 (Process for making Hepatitis B core protein modulators) held by ASSEMBLY BIOSCIENCES, INC. expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ASSEMBLY BIOSCIENCES, INC.
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P31/20